2-[(2E)-2-[1-(4-imidazol-1-ylphenyl)ethylidene]hydrazinyl]-4-methyl-1H-pyrimidin-6-one
C16H16N6O — CID 135576611
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[(2E)-2-[1-(4-imidazol-1-ylphenyl)ethylidene]hydrazinyl]-4-methyl-1H-pyrimidin-6-one
2-[(2E)-2-[1-(4-imidazol-1-ylphenyl)ethylidene]hydrazinyl]-4-methyl-1H-pyrimidin-6-one (PubChem CID 135576611) has the molecular formula C16H16N6O and a molecular weight of 308.35 g/mol. Its IUPAC name is 2-[(2E)-2-[1-(4-imidazol-1-ylphenyl)ethylidene]hydrazinyl]-4-methyl-1H-pyrimidin-6-one.
Molecular Properties
| Compound Name | 2-[(2E)-2-[1-(4-imidazol-1-ylphenyl)ethylidene]hydrazinyl]-4-methyl-1H-pyrimidin-6-one |
|---|---|
| PubChem CID | 135576611 |
| Molecular Formula | C16H16N6O |
| Molecular Weight | 308.35 g/mol |
| Exact Mass | 308.14 |
| IUPAC Name | 2-[(2E)-2-[1-(4-imidazol-1-ylphenyl)ethylidene]hydrazinyl]-4-methyl-1H-pyrimidin-6-one |
| SMILES | C/C(=N\Nc1nc(C)cc(=O)[nH]1)c1ccc(-n2ccnc2)cc1 |
| InChI | InChI=1S/C16H16N6O/c1-11-9-15(23)19-16(18-11)21-20-12(2)13-3-5-14(6-4-13)22-8-7-17-10-22/h3-10H,1-2H3,(H2,18,19,21,23)/b20-12+ |
| InChIKey | DWXJFTVULDJDOS-UDWIEESQSA-N |
| XLogP | 2.10 |
| TPSA | 87.96 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 23 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 308.35 |
| LogP ≤ 5 | 2.10 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135576611 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.